About
David Evans is a physician-scientist who joined Sofinnova Partners as Partner, bringing over 20 years of experience in drug development and pharmaceutical investment. He previously served as Senior Investment Director at the Roche Venture Fund and held senior roles at Bristol Myers Squibb and Eli Lilly in research and data science. His background also includes clinical practice with Médecins Sans Frontières, policy work at the World Bank, and training in medicine and epidemiology.
Invests in
BiotechDigital HealthHealthtech
Experience
- Aisling Capitalno title
Colleagues at Sofinnova Partners
Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners
Frequently asked questions
- Who is David Evans?
- David Evans is a physician-scientist who joined Sofinnova Partners as Partner, bringing over 20 years of experience in drug development and pharmaceutical investment. He previously served as Senior Investment Director at the Roche Venture Fund and held senior roles at Bristol Myers Squibb and Eli Lilly in research and data science. His background also includes clinical practice with Médecins Sans Frontières, policy work at the World Bank, and training in medicine and epidemiology.
- Where does David Evans work?
- David Evans is Partner at Sofinnova Partners.
- What does David Evans invest in?
- David Evans invests in Biotech, Digital Health, Healthtech.
Shared employers
Also worked at Aisling Capital10
Lloyd AppelChief Financial Officer at Differential VenturesAftab KheraniManaging Partner at Ajax HealthScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesAndrew SchiffManaging Partner at Aisling CapitalEric AguiarPartner at Aisling CapitalSunny ReddyPrincipal at Aisling Capital
+ 4 more